Rubra Medicaments Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 6.300 million compared to INR 3.000 million a year ago. Net loss was INR 62,000 compared to net income of INR 1.318 million a year ago. For the full year, total revenue was INR 9.876 million compared to INR 5.912 million a year ago. Net income was INR 315,000 compared to net loss of INR 114,000 a year ago.